MidCap Advisors

MidCap Advisors is pleased to welcome Hannah Figueroa as our new Originations Associate. Hannah will lead the firm's deal sourcing and outreach efforts, leveraging her background in strategic marketing and stakeholder engagement to cultivate new opportunities across our core industry verticals.

We are excited to have Hannah on board as we continue to expand our market presence and drive value for our clients.

To learn more about our team: https://hubs.la/Q03tltQ80

MidCap Advisors is pleased to welcome Richard S. Groberg as Managing Director. Richard has successfully completed more than $2.8 billion in M&A transactions and has deep expertise in multi-location healthcare providers, Physician Practice Management (PPM), and private equity-backed consolidations.

With over 30 years in healthcare M&A, Richard G. has worked on both the buy-side and sell-side, guiding transactions in an increasingly complex market. His insight into valuation, deal structuring, and ex*****on has helped business owners and investors navigate industry shifts with confidence.
We look forward to the impact he will have at MidCap Advisors.

Learn more about our healthcare practice: https://hubs.la/Q03cyYxr0

MidCap Advisors is pleased to welcome Lisa Sonneborn, MA, LMHC as Healthcare Senior Advisor. Lisa has over a decade of experience in pharmaceutical support services which includes owning, operating, growing, and selling businesses in the space.

Lisa is currently a founder, owner, and President of both a Clinical Research Organization (CRO) and phase 1-4 clinical trial site, conducting industry sponsored research for some of the world's most prominent pharmaceutical companies.

Lisa brings unique knowledge of operational models, a clear perspective of the CRO and site industry, and first-hand experience in the drug development and clinical trial M&A landscape to the MidCap team. Lisa’s distinctive perspective on the intricacies of clinical trials and her proven track record in scaling and selling will greatly benefit MidCap’s clients who support biotech and pharmaceutical companies.

Lisa founded Clarity Clinical Research, a dedicated Alzheimer’s and NASH trial facility, and successfully grew it into a high-performing research site that was later acquired by the world’s largest research network. Her deep understanding of clinical trial operations, healthcare M&A, and site-level strategy brings valuable insight to healthcare companies navigating growth and consolidation.

We look forward to the expertise she brings to MidCap Advisors.

Learn more about our healthcare practice: https://hubs.la/Q03cw7ZX0